Download
slide1 n.
Skip this Video
Loading SlideShow in 5 Seconds..
Global Alzheimer’s Disease Drugs Market PowerPoint Presentation
Download Presentation
Global Alzheimer’s Disease Drugs Market

Global Alzheimer’s Disease Drugs Market

465 Views Download Presentation
Download Presentation

Global Alzheimer’s Disease Drugs Market

- - - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

  1. Table of Contents Executive Summary 2. Global Alzheimer’s Disease - Drugs Market and Prevalence Analysis 2.1 Global Alzheimer’s Disease - Drugs Market and Forecast (2010 - 2020) 2.2 Global Alzheimer’s Disease - Prevalence and Forecast (2010 - 2020) 3. Global Alzheimer’s Disease - Country Wise Market Share and Forecast (2013 - 2020)

  2. 4. Global Alzheimer’s Disease - Drugs Sales and Forecast To 2020 4.1 Exelon (Rivastigmine) Sales and Forecast 4.2 Razadyne/ReminylSales and Forecast 4.3 Memary(Memantine) Sales and Forecast 4.4 Ebixa(Memantine) Sales and Forecast 4.5 Aricept (Donepezil) Sales and Forecast 4.6 RivastachSales and Forecast 4.7 Namenda (Memantine) Sales and Forecast 4.8 Nootropil(Piracetam) Sales and Forecast 4.9 Namzaric(Memantine and Donepezil) Sales and Forecast

  3. 5. Global Alzheimer’s Disease - Pipeline Drugs Analysis and Sales Forecast 5.1 Solanezumab Drugs Analysis and Sales Forecast 5.1.1 About Solanezumab 5.1.2 Clinical Trials 5.1.3 Solanezumab Drugs Sales Forecast 5.2 ABT-126 Drugs Analysis and Sales Forecast 5.2.1 About ABT-126 5.2.2 Clinical Trials 5.2.3 ABT-126 Drugs Sales Forecast

  4. Continue (www.igateresearch.com) 5.3 Idalopirdine Drugs Analysis and Sales Forecast 5.3.1 About Idalopirdine 5.3.2 Clinical Trials 5.3.3 Idalopirdine Drugs Sales Forecast 5.4 Gantenerumab Drugs Analysis and Sales Forecast 5.4.1 About Gantenerumab 5.4.2 Clinical Trials 5.4.3 Gantenerumab Drugs Sales Forecast

  5. Continue (www.igateresearch.com) 5.5 Crenezumab Drugs Analysis and Sales Forecast 5.5.1 About Crenezumab 5.5.2 Clinical Trials 5.5.3 Crenezumab Drugs Sales Forecast 5.6 Lu AE58054 Drugs Analysis and Sales Forecast 5.6.1 About Lu AE58054 5.6.2 Clinical Trials 5.6.3 Lu AE58054 Drugs Sales Forecast 5.7 BIIB037 Drugs Analysis and Sales Forecast 5.7.1 About BIIB037 5.7.2 Clinical Trials 5.7.3 BIIB037 Drugs Sales Forecast

  6. 6. Alzheimer’s Disease Drugs Market & Prevalence - Country Wise Analysis 6.1 United States - Alzheimer’s Disease Drugs Market & Prevalence Analysis 6.1.1 United States - Alzheimer’s Disease Drugs Market & Forecast (2013 - 2020) 6.1.2 United States - Alzheimer’s Disease Prevalence & Forecast (2010 - 2020) 6.2 France - Alzheimer’s Disease Drugs Market and Prevalence Analysis 6.2.1 France - Alzheimer’s Disease Drugs Market and Forecast (2013 - 2020) 6.2.2 France - Alzheimer’s Disease Prevalence and Forecast (2012 - 2020) 6.3 Germany - Alzheimer’s Disease Drugs Market and Prevalence Analysis 6.3.1 Germany - Alzheimer’s Disease Drugs Market and Forecast (2013 - 2020) 6.3.2 Germany - Alzheimer’s Disease Prevalence and Forecast (2012 - 2020)

  7. Continue (www.igateresearch.com) 6.4 Italy - Alzheimer’s Disease Drugs Market and Prevalence Analysis 6.4.1 Italy - Alzheimer’s Disease Drugs Market and Forecast (2013 - 2020) 6.4.2 Italy - Alzheimer’s Disease Prevalence and Forecast (2012 - 2020) 6.5 Spain - Alzheimer’s Disease Drugs Market & Prevalence Analysis 6.5.1 Spain - Alzheimer’s Disease Drugs Market & Forecast (2013 - 2020) 6.5.2 Spain - Alzheimer’s Disease Prevalence & Forecast (2012 - 2020) 6.6 United Kingdom - Alzheimer’s Disease Drugs Market & Prevalence Analysis 6.6.1 United Kingdom - Alzheimer’s Disease Drugs Market & Forecast (2013 - 2020) 6.6.2 United Kingdom - Alzheimer’s Disease Prevalence & Forecast (2012 - 2020)

  8. Continue (www.igateresearch.com) 6.7 Japan - Alzheimer’s Disease Drugs Market & Prevalence Analysis 6.7.1 Japan - Alzheimer’s Disease Drugs Market & Forecast (2013 - 2020) 6.7.2 Japan - Alzheimer’s Disease Prevalence & Forecast (2012 - 2020) 6.8 China - Alzheimer’s Disease Drugs Market & Prevalence Analysis 6.8.1 China - Alzheimer’s Disease Drugs Market & Forecast (2013 - 2020) 6.8.2 China - Alzheimer’s Disease Prevalence & Forecast (2010 - 2020) 6.9 India - Alzheimer’s Disease Drugs Market & Prevalence Analysis 6.9.1 India - Alzheimer’s Disease Drugs Market & Forecast (2013 - 2020) 6.9.2 India - Alzheimer’s Disease Prevalence & Forecast (2010 - 2020)

  9. 7. Global Alzheimer’s Disease Drugs Market - Major Deals Analysis 7.1 Global Alzheimer’s Disease Drugs Market - Strategic Alliance 7.2 Global Alzheimer’s Disease Drugs Market - Licensing Agreement 7.3 Global Alzheimer’s Disease Drugs Market - Collaboration Deals 7.4 Global Alzheimer’s Disease Drugs Market - Mergers and Acquisitions 8. Global Alzheimer’s Disease Drugs Research - Funding Analysis 8.1 National Institute of Health (2011 - 2016) 8.2 Alzheimer's Association (2011 - 2014) 8.3 Cure Alzheimer’s Fund (2008 - 2014) 8.4 Alzheimer’s Drug Discovery Foundation (2008 - 2013) 8.5 BrightFocusFoundation (2010 - 2014)

  10. 9. Global Alzheimer’s Disease Drug Market - Driving Factors 9.1 Growing Aging Population 9.1.1 Global Ageing Indicators 9.1.2 Population Aged 60 or Over: World and Development Regions, 1950 - 2050 9.1.3 Worldwide - Distribution of Population Aged 60 Years or Over By Broad Age Group, 1950 – 2050 9.2 Unmet Medical Needs 9.3 Strong Pipeline Candidate Expected to Drive Alzheimer’s Disease Drugs Market 9.4 Future Drugs for Disease Modification in Alzheimer’s Disease

  11. 10. Global Alzheimer’s Disease Drug Market - Challenges 10.1 Lack of Validated Targets & Lack of Animal Models 10.2 Barriers in the Design and Implementation of Clinical Trials 10.3 Barriers in Academia & Regulatory Issues 10.4 Alzheimer’s Drug Failure: Insinuation for Future R&D in Neuroscience 10.5 Costly Alzheimer’s Drug Development Dissuade Drug Companies 10.6 Research Setbacks and Stepping Stones 10.7 Country Wise Barriers to Growth for Alzheimer’s Disease Drugs Market 10.7.1 Unite States 10.7.2 France 10.7.3 Germany 10.7.4 United Kingdom 10.7.5 Japan 10.7.6 China 10.7.7 India

  12. Source of Information iGATERESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.

  13. Published By iGATE RESEARCH Phone: +91-858-684-0791 (India) +91-706-527-9335 (India) Email: info@igateresearch.com Internet:www.igateresearch.com

  14. Format • Report Title: Global Alzheimer’s Disease Drugs Market and Pipeline Drugs Market Analysis to 2020 • To Order the Report Visit: • http://www.igateresearch.com/ProductDetail.php?pd_name=Global%20Alzheimers%20Disease%20Drugs%20Market%20Analysis

  15. Order the Report • iGATE RESEARCH PVT. LTD. • Web: www.igateresearch.com • To order the Report: • E-Mail:  info@igateresearch.com • Contact No. : +91-858-684-0791, +91-706-527-9335 (INDIA) • For Report Related Query: • E-Mail:  info@igateresearch.com • Contact No. : +91-858-684-0791, +91-706-527-9335 (INDIA)